> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Xavant Tech’s Waveform Neuromodulator
- URL: https://www.fdaweb.com/fda-clears-xavant-techs-waveform-neuromodulator/
- Published: 2017-08-01T12:00:00.000Z
- Updated: 2026-09-14T22:38:05.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139276

FDA has cleared a Xavant Technology 510(k) for the Stimpod NMS460, a hybrid-pulsed radio frequency waveform neuromodulation device for relieving and managing chronic intractable pain, as well as an adjunctive treatment in managing post-surgical pain, post-traumatic acute pain problems, and an adjunct for pain control due to rehabilitation. The device applies its waveform to affected areas transcutaneously, according to the company. “This waveform creates electromagnetic effects similar to invasive pulsed radio frequency treatments, and several case studies have shown instant and dramatic relief of chronic intractable pain,” it says. “The Stimpod NMS460 also incorporates the nerve-locating technology which features a nerve mapping probe that enables practitioners to locate nerves and evaluate the treatment progress of damaged nerves.”